General Announcement::HYPHENS PHARMA INTERNATIONAL LIMITED MAKES STRONG LISTING DEBUT ON THE CATALIST BOARD OF THE SGX-ST

Issuer & Securities

Announcement Title: General Announcement
Date &Time of Broadcast: 18-May-2018 18:56:54
Status: New
Announcement Sub Title: HYPHENS PHARMA INTERNATIONAL LIMITED MAKES STRONG LISTING DEBUT ON THE CATALIST BOARD OF THE SGX-ST
Announcement Reference: SG180518OTHRFKTQ
Submitted By (Co./ Ind. Name): Lim See Wah
Designation: Executive Chairman and CEO
Description (Please provide a detailed description of the event in the box below): Please refer to the attached.

This announcement has been prepared by the Company and its contents have been reviewed by DBS Bank Ltd. (the "Sponsor") for compliance with the Rules of Catalist. The Sponsor has not independently verified the contents of this announcement. This announcement has not been examined or approved by the SGX-ST. The SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact persons of the Sponsor are Heng Mui Mui, Managing Director and Kelvin Wong, Vice President at 12 Marina Boulevard Level 46, Marina Bay Financial Centre Tower 3, Singapore 018982, Telephone +65 6878 8888.

Total size =545K